Tag: PCI
-
Mediating the Link: Physical Activity Self-Efficacy in Elderly Post-PCI Patients
Introduction Cardiovascular disease remains a leading cause of morbidity among the elderly. For patients who have undergone percutaneous coronary intervention (PCI), early engagement in physical activity (PA) is a key component of cardiac rehabilitation and long-term recovery. Recent research suggests that physical activity self-efficacy—an individual’s confidence in their ability to be physically active—may mediate the…
-
Understanding COP-INH: A New Marker for Post-PCI Risk in ACS Patients
Introduction Dual antiplatelet therapy (DAPT), pairing aspirin with a P2Y12 receptor antagonist, is a cornerstone after percutaneous coronary intervention (PCI) with drug-eluting stents. While effective at reducing stent thrombosis and major adverse cardiac events (MACE), patient responses to clopidogrel and aspirin vary. High residual platelet reactivity (HRPR) after clopidogrel treatment correlates with worse outcomes, underscoring…
-
COP-INH Score: A New Way to Predict Post-PCI Risks in ACS Patients
Understanding the Need for Better Post-PCI Risk Prediction Dual antiplatelet therapy (DAPT), typically aspirin plus a P2Y12 receptor antagonist, is standard after percutaneous coronary intervention (PCI) with drug-eluting stents. While this approach reduces stent thrombosis and major adverse cardiac events (MACE), individual responses to antiplatelet drugs vary widely. High residual platelet reactivity (HRPR) after clopidogrel…
-
COP-INH Score: A New Metric for Predicting Post-PCI Outcomes in ACS Patients
Understanding the Challenge: Platelet Reactivity After PCI Dual antiplatelet therapy (DAPT), typically aspirin plus a P2Y12 receptor antagonist, is standard care after percutaneous coronary intervention (PCI) with drug-eluting stents. While this regimen reduces stent thrombosis and major adverse cardiac events (MACE), patient responses vary. High residual platelet reactivity (HRPR) after clopidogrel therapy has been linked…
-
Closing the gender gap in heart disease care worldwide today
Closing the gender gap in heart disease care: a persistent challenge Cardiovascular disease in women has long been under-recognised, under-diagnosed, and under-treated. Decades after Bernadine Healy highlighted sex bias in coronary artery disease management, disparities persist in Australia and internationally. Recent analyses, including a study from New South Wales, reveal that while progress is possible,…
-
Bridging the Gap: Women’s Heart Attack Care Improves but Still Trails Men
Overview: A Slow but Steady Improvement in Women’s Heart Attack Care New findings from researchers at the University of Sydney, published in the Medical Journal of Australia, reveal that while outcomes for women experiencing a heart attack are improving, the gender gap in care and outcomes persists. Analyzing hospital records of nearly 30,000 NSW patients…
-
Closing the Gap: Sex Differences in STEMI Management and Outcomes in New South Wales (2011–2020)
Understanding the NSW STEMI Landscape (2011–2020) Cardiovascular disease remains a leading cause of death for all adults, yet women with ST‑elevation myocardial infarction (STEMI) have historically faced under-recognition and undertreatment. A comprehensive retrospective cohort study of STEMI admissions in New South Wales (NSW), Australia, from 2011 to 2020 sheds light on how sex differences in…
-
Women’s Heart Attack Care Improves but Gap Persists, Australian Study Finds
Overview: A Step Forward, Yet Not Fast Enough New findings from the Medical Journal of Australia reveal that care for women experiencing a heart attack is improving in NSW, Australia, but the pace of that improvement leaves a persistent gender gap. An analysis of hospital records and outcomes for nearly 30,000 patients over nine years…
-
Closing the Gap: Sex Differences in STEMI Management and Outcomes in New South Wales, 2011–2020
Background: Sex gaps in STEMI care persist but are shrinking Cardiovascular disease remains a leading cause of death for both men and women, yet women historically received less invasive care and preventive therapy for acute coronary syndromes. This retrospective cohort study from New South Wales (NSW), covering 2011–2020, examines whether sex differences in the management…
-
Women’s Heart Attack Care Improving but Gap Remains
What the study found A large Australian study has found that care for women experiencing a heart attack is improving, but not quickly enough to close the gap with men. An analysis of hospital records from New South Wales (NSW) spanning 2011 to 2020 included 29,435 adults who suffered a STEMI (a severe, complete artery…